Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Your gut microbiome might be doing more than you think. Northwestern Medicine researchers found that butyrate — a compound gut bacteria produce from dietary fiber — can reprogram intestinal lining cells to keep promoting anti-inflammatory responses long after the compound itself is gone. In mice, this "trained" gut memory reduced the severity of colitis-like disease, pointing to exciting new possibilities for treating inflammatory bowel disease.
Your gut microbiome might be doing more than you think. Northwestern Medicine researchers discovered that butyrate — a compound produced when gut bacteria ferment dietary fiber — can reprogram intestinal epithelial cells (IECs) to keep promoting anti-inflammatory immune responses long after the compound itself has cleared the system. Published in Nature Communications, the study challenges the traditional view of IECs as short-lived barrier cells, suggesting they can retain a durable molecular "imprint" of beneficial microbial signals.
In mouse experiments, butyrate treatment led to sustained elevated production of IL-10 (an immune-calming cytokine) in CD4+ T-cells even two weeks after treatment stopped. Treated mice were also significantly more resistant to chemically induced colitis. Crucially, the effect held up in germ-free mice — meaning it doesn't depend on ongoing microbial activity. The team identified a key molecular pathway: butyrate activates the enzyme Sat1 in IECs, which boosts production of a metabolite called N1-acetylspermidine that in turn drives IL-10 production in T-cells.
Key Takeaways:
Why it matters: Inflammatory bowel disease affects millions worldwide and remains difficult to manage long-term. If this gut "training" mechanism translates to humans, it could open the door to dietary or metabolite-based strategies that restore immune tolerance — potentially reducing flares and the need for chronic medication.
